-+ 0.00%
-+ 0.00%
-+ 0.00%

*Rhythm Pharmaceuticals Receives Positive CHMP Opinion For IMCIVREE(R) (setmelanotide) For The Treatment Of Obesity And Control Of Hunger In Patients With Acquired Hypothalamic Obesity Due To Hypothalamic Injury Or Impairment >RYTM

Dow Jones·03/26/2026 13:01:00

Please log in to view news